Three ustekinumab biosimilars enter the US market, expanding access to more affordable options referencing Stelara ...

Amgen has set up this new centre in Hyderabad to further technologically develop its range of medicines. It is developing the ...

Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...

Recent developments in the health sector include Pfizer appointing Patrizia Cavazzoni as Chief Medical Officer and Amgen ...

Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...

Alvotech and Teva Pharmaceuticals (“Teva”) announced that the U.S. Food and Drug Administration (FDA) has accepted for review ...

Hyderabad: Amgen, a biotechnology major from the US, is making an investment of Rs 1,600 crore in Hyderabad by 2025-end. As ...

The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...

Amgen invests $200M in India's tech center to leverage AI for drug development. The U.S. FDA seeks to rehire 300 staff ...

The employees at the new Amgen campus will reach to 600 by the end of this year and is expected to provide employment to over ...

Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI ...

Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’ ...